Human Cardiac Drug Response Prediction
Human Cardiac Drug Response Prediction
FilamenTech applies MUSICO to help teams translate molecular, tissue, animal, and mutation data into human-relevant cardiac predictions for better program decisions.
MUSICO is designed for programs where molecular, sarcomere, tissue, or animal data must be translated into human cardiac functional response. We focus first on cardiac and muscle programs where mechanistic interpretation matters.
Cardiac drug programs often need to decide which mechanisms, compounds, or experimental signals are most likely to translate into human benefit or risk. MUSICO helps teams connect early experimental findings to human-relevant cardiac predictions before the next high-cost study.
Your experimental data may come from mouse, rat, porcine tissue, hiPSC-derived cardiomyocytes, engineered heart tissues, trabeculae, or other cardiac preparations. MUSICO helps translate those findings into human-relevant cardiac response predictions using mechanistic, physics-based models.
Inherited cardiomyopathies are not one mechanism. Different variants can affect calcium sensitivity, force generation, relaxation, sarcomere kinetics, and tissue-level function in different ways. MUSICO helps connect mutation-level changes to cardiac functional consequences and therapeutic response hypotheses.
A drug or mutation can change cardiac behavior through several interacting mechanisms. MUSICO helps separate these effects and identify which molecular or tissue-level mechanisms are most likely driving the observed functional response.
Mechanistic simulations can provide insight into:
FilamenTech collaborates with pharmaceutical companies, biotechnology organizations, and
research institutions developing therapies for inherited cardiomyopathies and related muscle
disorders.
Assess whether your existing data can support a MUSICO prediction workflow and define the right modeling question.
Generate a decision-grade mechanistic prediction package for one program question.
Support compound ranking, mechanism interpretation, species translation, and translational decision-making across a broader program.
Start with one program question and the data you already have. We will help determine whether a focused MUSICO analysis can support your next decision.
Human cardiac prediction from data you already have.
FilamenTech develops multiscale mechanistic simulation workflows that help drug-development teams translate assay, tissue, animal, mutation, and structural data into human-relevant cardiac and muscle predictions.
Boston • Belgrade
Start with a focused pilot.
Evaluate mutation effects, drug responses, or translational hypotheses using mechanistic simulation workflows tailored to your program.
© 2026 FilamenTech. All rights reserved.
Created by Starter studio.